ALL vs GMED · P/E 4.9, rev $18.60B vs P/E 42, rev $1.55B
The Allstate Corporation (ALL) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the ALL and GMED stock pages for the full models.
Not investment advice.